News

Latest news in the field of endometriosis: clinical and scientific research, updates from national support groups – and general news on progress.


Historic decision for women’s health made by the European Commission
16 February 2006

EU Community Public Health Programme (2006) now includes specific reference to the need for “information and definition of indicators to improve relevant information for specific aspects of women’s gynaecological and menopausal health (eg. endometriosis)”.

HLA I expression raised in endometriosis
15 February 2006

February 2006 Researchers in Barcelona suggest that expression of class I human leukocyte antigen (HLA I) is significantly higher in endometrial samples from patients with endometriosis than in those from other people. In a cross sectional study, 32 patients who underwent an operation were diagnosed as having only endometriosis were enrolled, alongside a control group […]

Pre-IVF GnRH agonists boost pregnancy rates for endometriosis patients
15 February 2006

February 2006 A Cochrane review has found that endometriosis patients who use gonadotropin-releasing hormone (GnRH) agonists in the run-up to IVF have improved outcomes. In a systematic review of the existing literature, reviewers, led by Professor Hassan Sallam, from Alexandria University in Egypt, found that giving GnRH agonists to women with endometriosis for 3-6 months […]

Picture of Maria Rauch-Kallat World Endometriosis Society welcomes Austrian EU-presidency initiative: Austrian Health Minister urges more awareness for endometriosis
24 January 2006

Maria Rauch-Kallat is taking action and will focus on women’s health, and endometriosis in particular, during the Austrian EU presidency in 2006.

WCE2005: Highlights from the 9th World Congress on Endometriosis
15 January 2006

The 9th World Congress on Endometriosis (WCE2005) focused on the patient as the partner, organising networks of specialist care, prevention of endometriosis, support groups, awareness, diagnostic tools and better treatments.

Treatment of symptomatic rectovaginal endometriosis with an oestrogen-progestogen combination versus low-dose norethindrone acetate
15 November 2005

November 2005 Scientists in Italy have demonstrated that low-dose norethindrone acetate could be considered an effective, tolerable, and inexpensive first-choice medical alternative to repeat surgery for treating symptomatic rectovaginal endometrioti lesions in patients who do not seek conception. In order to evaluate the efficacy, safety and tolerability of an oestrogen-progestogen combination versus low-dose norethindrone acetate, […]

Endometriosis severity affects IVF outcome
15 November 2005

November 2005 Women with moderate-to-severe endometriosis are less likely to fall pregnant and have a baby with the help of IVF than those with minimal-to-mild disease, researchers have shown, according to Finish researchers. “Women with endometriosis often need IVF to conceive—most women need several cycles of treatment,” note the researchers, led by Paula Kuivasaari from […]

Logo from Associazione Italiana Endometriosi Onlus (AIE) More progress made by the Italian Endometriosis Association towards their legislative awareness campaign
18 October 2005

Jacqueline Veit (co-founder/president of Associazione Italiana Endometriosi was received at the Senate for an audience as part of the investigation currently underway on the issue of endometriosis as a social disease.

Infertility researchers identify one gene’s critical role in the human embryo implantation process
15 October 2005

October 2005 Researchers at Cedars-Sinai Medical Center and the University of California at Los Angeles recently conducted a study of the molecular mechanism involved in the human implantation process, specifically targeting the role of one gene in the success of an embryo to implant itself in the endometrium, the inner lining of the uterus. “There […]

Endostatin is a promising non-toxic endometriosis treatment
15 October 2005

October 2005 Antiangiogenic therapy with endostatin may present a promising novel, non-toxic therapeutic option for patients with endometriosis. Researchers at the Department of Surgery, Children’s Hospital, Harvard Medical School in Boston, USA, have shown that an anti-angiogenic protein hinders the development of endometriosis in mice without any apparent negative effects on fertility or reproduction. As […]

Stay up to date

Register for endometriosis news:

Connect

Twitter Follow us on Twitter

Get involved

Help us improve treatments for endometriosis and prevent this disease in the next generation of women. Support the work of the World Endometriosis Research Foundation.

Donate to research Shop for WERF Volunteer